[Comparative effect of hormonal and salicylate treatments on leukocytosis during Bouillaud's disease].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D003348:Cortisone / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use*; D007960:Leukocyte Disorders; D007964:Leukocytosis / Q000150:complications*; D012213:Rheumatic Fever / Q000150:complications*; D012214:Rheumatic Heart Disease; D012459:Salicylates
D012459:Salicylates; D000324:Adrenocorticotropic Hormone; D001241:Aspirin; D003348:Cortisone; D006854:Hydrocortisone
ACETYLSALICYLIC ACID/therapeutic use; ACTH/therapeutic use; CORTISONE/therapeutic use; HYDROCORTISONE/therapeutic use; LEUKOCYTOSIS/complications; RHEUMATIC FEVER/complications
Influence comparée des traitements hormonaux et salicylés sur la leucocytose au cours de la maladie de Bouillaud.